Invention Grant
US09120784B2 1,3,4-oxadiazoles-2-thio azetidine derivatives as sphingosine-1 phosphate receptors modulators
有权
1,3,4-恶二唑-2-硫代氮杂环丁烷衍生物作为鞘氨醇-1磷酸受体调节剂
- Patent Title: 1,3,4-oxadiazoles-2-thio azetidine derivatives as sphingosine-1 phosphate receptors modulators
- Patent Title (中): 1,3,4-恶二唑-2-硫代氮杂环丁烷衍生物作为鞘氨醇-1磷酸受体调节剂
-
Application No.: US14070725Application Date: 2013-11-04
-
Publication No.: US09120784B2Publication Date: 2015-09-01
- Inventor: Janet A. Takeuchi , Ling Li , Wha-Bin Im , Ken Chow
- Applicant: Allergan, Inc.
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Barbara C. Potts
- Main IPC: C07D413/10
- IPC: C07D413/10 ; C07D413/12 ; C07D413/14
Abstract:
The present invention relates to substituted 1,3,4-oxadiazoles-2-thio azetidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
Public/Granted literature
- US20140128366A1 1,3,4-OXADIAZOLES-2-THIO AZETIDINE DERIVATIVES AS SPHINGOSINE-1 PHOSPHATE RECEPTORS MODULATORS Public/Granted day:2014-05-08
Information query
